![](/img/cover-not-exists.png)
Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial
Robert Carr, Peter Brocklehurst, Caroline J Doré, Neena ModiVolume:
373
Year:
2009
Language:
english
DOI:
10.1016/s0140-6736(09)60071-4
File:
PDF, 180 KB
english, 2009